HopeStage
Back to all studies
CompletedNCT04167306

Varenicline and Bupropion for Alcohol Use

About this title

Varenicline and Bupropion for Alcohol Use Disorder

Read the official source — NCT04167306
Medication studyAges 25–70SwedenAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 25 years to 70 years.

Listed locations
Malmö and 3 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: March 4, 2019
Recruitment status
Completed
Enrollment listed in the registry
388
Sponsor
Vastra Gotaland Region
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Sweden
Age range
From 25 Years to 70 Years
Official registry ID
NCT04167306
Official title
Show the full official title

A Randomized, Double-blind, Placebo-controlled Multicenter Trial on the Efficacy of Varenicline and Bupropion in Combination and Alone, for Treatment of Alcohol Use Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Malmö · Linköping · Stockholm

1 more locations
  • Gothenburg

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Vastra Gotaland Region.

Did this study involve medication?

Yes. The study involved medication, including Varenicline Tartrate 1 mg b.i.d and Bupropion Hydrochloride 150 mg b.i.d.

Who was this study for?

Listed age limits: 25 years to 70 years.

Want to explore more studies?

Explore studies